311 related articles for article (PubMed ID: 15652810)
1. Revealing urologic diseases by proteomic techniques.
Lee SW; Lee KI; Kim JY
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):203-13. PubMed ID: 15652810
[TBL] [Abstract][Full Text] [Related]
2. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
3. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers.
Saito M; Kimoto M; Araki T; Shimada Y; Fujii R; Oofusa K; Hide M; Usui T; Yoshizato K
Eur Urol; 2005 Nov; 48(5):865-71. PubMed ID: 15964125
[TBL] [Abstract][Full Text] [Related]
4. Application of proteomics in cancer gene profiling: two-dimensional difference in gel electrophoresis (2D-DIGE).
Hariharan D; Weeks ME; Crnogorac-Jurcevic T
Methods Mol Biol; 2010; 576():197-211. PubMed ID: 19882264
[TBL] [Abstract][Full Text] [Related]
5. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
Schiffer E; Mischak H; Novak J
Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
[TBL] [Abstract][Full Text] [Related]
6. Proteome studies of CSF in AD patients.
Davidsson P; Sjögren M
Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
[TBL] [Abstract][Full Text] [Related]
7. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
[TBL] [Abstract][Full Text] [Related]
9. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
10. What can proteomic analyses contribute to understanding the molecular biology and clinical behavior of prostate cancer?
Ware JL
Expert Rev Proteomics; 2004 Dec; 1(4):485-92. PubMed ID: 15966843
[TBL] [Abstract][Full Text] [Related]
11. Proteome analysis of prostate cancer.
Kuruma H; Egawa S; Oh-Ishi M; Kodera Y; Maeda T
Prostate Cancer Prostatic Dis; 2005; 8(1):14-21. PubMed ID: 15477873
[TBL] [Abstract][Full Text] [Related]
12. Urinary exosomes and proteomics.
Moon PG; You S; Lee JE; Hwang D; Baek MC
Mass Spectrom Rev; 2011; 30(6):1185-202. PubMed ID: 21544848
[TBL] [Abstract][Full Text] [Related]
13. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
14. Applications and current challenges of proteomic approaches, focusing on two-dimensional electrophoresis.
Vercauteren FG; Arckens L; Quirion R
Amino Acids; 2007 Sep; 33(3):405-14. PubMed ID: 17136510
[TBL] [Abstract][Full Text] [Related]
15. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
16. Proteomic toolbox for autoimmunity research.
Wu T; Mohan C
Autoimmun Rev; 2009 Jun; 8(7):595-8. PubMed ID: 19393208
[TBL] [Abstract][Full Text] [Related]
17. Multidimensional chromatography: a powerful tool for the analysis of membrane proteins in mouse brain.
Lohaus C; Nolte A; Blüggel M; Scheer C; Klose J; Gobom J; Schüler A; Wiebringhaus T; Meyer HE; Marcus K
J Proteome Res; 2007 Jan; 6(1):105-13. PubMed ID: 17203954
[TBL] [Abstract][Full Text] [Related]
18. Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers.
Schwamborn K; Gaisa NT; Henkel C
Expert Rev Proteomics; 2010 Dec; 7(6):897-906. PubMed ID: 21142890
[TBL] [Abstract][Full Text] [Related]
19. Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection.
Solassol J; Marin P; Demettre E; Rouanet P; Bockaert J; Maudelonde T; Mangé A
Anal Biochem; 2005 Mar; 338(1):26-31. PubMed ID: 15707932
[TBL] [Abstract][Full Text] [Related]
20. [Application of proteomic approach for solid tumor marker discovery].
Ni XG; Zhao P; Liu Y; Zhao XH
Ai Zheng; 2003 Jun; 22(6):664-7. PubMed ID: 12948422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
